Product Category
Advanced Multiphase Reconstruction Blends, Extracellular Matrix Catalysts & Angiogenic Modulators
Action on the Human Body
This triple-action master matrix leverages three independent biological pathways to deliver unparalleled systemic and structural tissue rebuilding. BPC-157 acts as an early responder, accelerating angiogenesis via the upregulation of vascular endothelial growth factor (VEGF) and balancing nitric oxide pathways to form functional granular tissue. TB-500 operates at the foundational cytoskeletal level, binding to G-actin to facilitate rapid cellular migration and keratinocyte motility across injured regions. GHK-Cu serves as an epigenetic remodeling vector, interacting with nuclear receptors to balance tissue-destructive metalloproteinases while directly upgrading systemic type I and type III collagen synthesis. Together, this 70mg formulation maximizes collagen density, accelerates the structural repair of severe tissue tears, down-regulates pro-inflammatory cytokines, and creates an optimized biological environment for structural tissue recovery.
What to Expect if Consumed
Expect profound acceleration in deep tendon and muscular recovery timelines, visible structural improvements in dermal elasticity and integrity, rapid clearing of chronic joint swelling, and comprehensive soft tissue repair.
Possible Therapy Combinations
Can be layered with Cortagen to promote simultaneous neuro-structural repair pathways, or combined with NAD+ to ensure optimal intracellular ATP generation during heavy tissue reconstruction loops.
Molecular Formula & Chemical Composition
Composition: Premium Triple-Blend consisting of BPC-157, Thymosin Beta-4 Fragment, and Copper Peptide Matrix. Purity: >99% Pure Lyophilized Tri-Matrix Mass.
WARNING: This peptide compound must be handled and utilized exclusively under very high, correct professional and qualified medical supervision. Misuse can lead to unintended biological variations.
Scientific References
1. Pickart, L., et al. (2015). ‘Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of New Gene Data.’ International Journal of Molecular Sciences.
2. Sikiric, P., et al. (2020). ‘Stable Gastric Pentadecapeptide BPC 157, Muco-Cutaneous Junction Gaps, and Deep Tissue Recovery.’ Frontiers in Pharmacology.






Reviews
There are no reviews yet.